Pfizer bets on biotech flu vaccine in $425 mln BioNTech alliance
August 16, 2018 at 01:00 AM EDT
Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.
